מנבאו

Țară: Israel

Limbă: ebraică

Sursă: Ministry of Health

Ingredient activ:

MENINGOCOCCAL VACCINES GROUP A; MENINGOCOCCAL VACCINES GROUP C; MENINGOCOCCAL VACCINES GROUP W; MENINGOCOCCAL VACCINES GROUP Y

Disponibil de la:

GLAXO SMITH KLINE (ISRAEL) LTD

Codul ATC:

J07AH02

Forma farmaceutică:

POWDER AND SOLVENT FOR SOLUTION FOR INJECTION

Compoziție:

MENINGOCOCCAL VACCINES GROUP Y 5 MCG / 0.5 ML; MENINGOCOCCAL VACCINES GROUP W 5 MCG / 0.5 ML; MENINGOCOCCAL VACCINES GROUP C 5 MCG / 0.5 ML; MENINGOCOCCAL VACCINES GROUP A 10 MCG / 0.5 ML

Calea de administrare:

תוך-שרירי

Tip de prescriptie medicala:

מרשם נדרש

Produs de:

GLAXO SMITHKLINE VACCINES S.R.L., ITALY

Grupul Terapeutică:

OTHER MENINGOCOCCAL MONOVALENT PURIFIED POLYSACCHARIDES ANTIGEN

Zonă Terapeutică:

OTHER MENINGOCOCCAL MONOVALENT PURIFIED POLYSACCHARIDES ANTIGEN

Indicații terapeutice:

Menveo is indicated for active immunization of children (2 years of age and above), adolescents and adults up to the age of 55 years, at risk of exposure to Neisseria meningitidis groups A, C, W135 and Y, to prevent invasive disease. The use of this vaccine should be in accordance with official recommendations.

Rezumat produs:

החיסון יינתן עבור חולה הלוקה באחד מאלה:1. אספלניה, היפוספלניה אנטומית או תפקודית, נרכשת או מולדת.2. חסר במערכת המשלים כגון חסר בפקטור D, פרופרידין ובמרכיב המשלים C5-9 או C3

Data de autorizare:

2017-08-31